ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 155 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $570,339 | -10.5% | 385,364 | -2.6% | 0.01% | 0.0% |
Q2 2023 | $636,906 | -45.0% | 395,594 | -0.9% | 0.01% | -54.2% |
Q1 2023 | $1,158,016 | -10.2% | 399,316 | +1.6% | 0.02% | -14.3% |
Q4 2022 | $1,289,689 | -14.4% | 393,198 | -1.3% | 0.03% | -20.0% |
Q3 2022 | $1,506,000 | -54.9% | 398,414 | -7.1% | 0.04% | -52.1% |
Q2 2022 | $3,340,000 | -16.4% | 428,707 | -0.2% | 0.07% | +2.8% |
Q1 2022 | $3,993,000 | -43.7% | 429,766 | -4.4% | 0.07% | -41.8% |
Q4 2021 | $7,087,000 | -12.4% | 449,704 | -0.5% | 0.12% | -18.1% |
Q3 2021 | $8,088,000 | +11.4% | 451,827 | -3.2% | 0.15% | +13.7% |
Q2 2021 | $7,261,000 | +9.9% | 466,947 | +1.5% | 0.13% | +4.0% |
Q1 2021 | $6,607,000 | -33.4% | 460,094 | -8.9% | 0.13% | -37.3% |
Q4 2020 | $9,914,000 | +41.5% | 505,049 | -6.6% | 0.20% | +21.1% |
Q3 2020 | $7,006,000 | -12.9% | 540,577 | -2.1% | 0.17% | -16.2% |
Q2 2020 | $8,042,000 | +121.8% | 551,930 | +29.6% | 0.20% | +80.0% |
Q1 2020 | $3,625,000 | -32.1% | 425,970 | +31.5% | 0.11% | -6.0% |
Q4 2019 | $5,337,000 | – | 324,020 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
Baupost Group | 8,123,616 | $26,645 | 0.44% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |